Filing Details
- Accession Number:
- 0001140361-14-012989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-17 17:08:06
- Reporting Period:
- 2014-03-13
- Filing Date:
- 2014-03-17
- Accepted Time:
- 2014-03-17 16:08:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1319606 | Andrew Miller | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-13 | 17,265 | $35.72 | 21,849 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-13 | 17,265 | $55.55 | 4,584 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock option (right to buy) | Disposition | 2014-03-13 | 17,265 | $0.00 | 17,265 | $35.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
31,485 | 2019-04-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on July 22, 2013.
- 25% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.